Thursday, December 6, 2012

• The Worst of 2012: Dendreonat Motley Fool (Thu, Dec 6)
• OncoSec Medical: 2013 Will Be A Year Of Crucial Eventsat Seeking Alpha (Thu, Dec 6)

Wednesday, December 5, 2012

• GHSU preps for Provenge cancer treatment clinical trialat bizjournals.com (Wed, Dec 5)
• This Just In: Upgrades and Downgradesat Motley Fool (Wed, Dec 5)

Monday, December 3, 2012

• SEC Sleuth: Abbott Labs, Questcor, Dendreon, Express Scripts, and MAKO Surgicalat Motley Fool (Mon, Dec 3)
• 5 Superball Stocksat Motley Fool (Mon, Dec 3)
• Here's What This $20 Billion Hedge Fund Has Been Buyingat Motley Fool (Mon, Dec 3)
• Dendreon Cautiously Approaches $5/Share (Again)at Seeking Alpha (Mon, Dec 3)

Sunday, December 2, 2012

• Exelixis' Crowning Achievementat Motley Fool (Sun, Dec 2)
• One Person's Trash Is Another Person's Treasure Selection: Dendreonat Motley Fool (Sun, Dec 2)
• A Commercial-Stage Biotech at Lastat Motley Fool (Sun, Dec 2)

Friday, November 30, 2012

• Insider Activity: Celsion Corporationat Motley Fool (Fri, Nov 30)

Thursday, November 29, 2012

• Prostate Cancer Market Takes Shape - Part 2: Treatments In Clinical Developmentat Seeking Alpha (Thu, Nov 29)
• How to Pick The Next Biotech Winnerat Forbes (Thu, Nov 29)

Wednesday, November 28, 2012

• Best Biotechnology and Pharmaceutical Investing Interviews of 2012: Oncology Treatments Expert Analyst Details his MethodologyWall Street Transcript (Wed, Nov 28)

Tuesday, November 27, 2012

• Dendreon Announces Webcast Presentations at Upcoming ConferencesBusiness Wire (Tue, Nov 27)
• Will Dendreon’s Stock Skyrocket Again?at Wall St. Cheat Sheet (Tue, Nov 27)

Sunday, November 25, 2012

• Dendreon On The Ropesat Seeking Alpha (Sun, Nov 25)

Friday, November 23, 2012

• Is Dendreon DOA in Europe?at Motley Fool (Fri, Nov 23)
• Why Do Amarin Shareholders Want a Buyout?at Motley Fool (Fri, Nov 23)

Wednesday, November 21, 2012

• 5 Quick Movers To Examine Againat Seeking Alpha (Wed, Nov 21)
• What's Changed With Dendreon?at Motley Fool (Wed, Nov 21)
• Therapeutic Cancer Vaccines: From The Underwhelming To The Excitingat Seeking Alpha (Wed, Nov 21)

Monday, November 19, 2012

• 4 Speculative Investments You Might Want To Considerat Seeking Alpha (Mon, Nov 19)

Sunday, November 18, 2012

• This Top-Dollar Drug Hits the Discount Rackat Motley Fool (Sun, Nov 18)

Add DNDN News to My Yahoo!